• LLY-507: A Compartment-Aware SMYD2 Strategy

  2026-09-02

  LLY-507 is a selective SMYD2 inhibitor for dissecting methyltransferase-dependent signaling in cancer and renal fibrosis models. This article presents an evidence-calibrated strategy that connects substrate selectivity, cellular compartment, orthogonal assays, and translational limitations.

• BCECF-AM: Turning pH Into Translational Insight

  2026-09-02

  BCECF-AM converts intracellular pH from a hidden variable into a decision-ready phenotype. This thought-leadership guide connects ratiometric imaging with secretion biology, cross-species validation, assay strategy, and translational interpretation.

• Cy3 TSA Fluorescence System Kit for HCC Imaging

  2026-09-01

  The Cy3 TSA Fluorescence System Kit converts weak HRP activity into a dense, localized fluorescent deposit for IHC, ICC, and ISH. Its strongest use-case is resolving low-abundance targets such as regulatory RNAs or metabolic proteins in fixed HCC cells and tissues when conventional fluorescence microscopy detection is insufficient.

• WST-8 Glucose Uptake Assay Kit in Delivery Studies

  2026-09-01

  The WST-8 Glucose Uptake Assay Kit provides a non-radioactive way to connect ion-tuned CPP/nucleic acid delivery with cellular metabolic phenotype. This guide explains the assay mechanism, controls, interpretation limits, and experimental decisions needed to distinguish altered glucose handling from delivery-related cytotoxicity.

• Triamcinolone B1859: Practical Lab Guide

  2026-08-31

  Triamcinolone (B1859) is a synthetic glucocorticoid agonist for controlled in vitro studies of glucocorticoid signaling, inflammation, and immunosuppression. This guide covers solvent selection, storage, assay setup, and quality control while defining why the compound should not be used for diagnostic, clinical, or therapeutic applications.

• N-MYC–eIF4G1 Survival Axis in inv(16) AML

  2026-08-31

  Peramangalam et al. identify a previously unrecognized MYCN enhancer and show that N-MYC sustains inv(16) acute myeloid leukemia through the translation-initiation factor eIF4G1. By integrating transcriptomic analysis, enhancer studies, functional perturbation, and patient-derived xenograft models, the study connects CBFβ-SMMHC-associated transcriptional deregulation with leukemic cell survival.

• Paclitaxel (Taxol) in TNBC Assay Design

  2026-08-30

  Paclitaxel and Taxol remain essential tools for cancer research, but their greatest value emerges when microtubule phenotypes are connected to subtype-specific resistance biology. This guide develops a resistance-aware assay framework for breast cancer research, informed by a key study of ceritinib and paclitaxel in triple-negative breast cancer.

• PreScission Protease for Precision Tag Cleavage

  2026-08-29

  PreScission Protease combines sequence-selective HRV 3C protease activity with low-temperature processing for recovering native-like recombinant proteins. This article translates the dKeap1–lamin Dm0 findings into practical purification, interaction-assay, and troubleshooting workflows.

• (-)-Blebbistatin in Cardiac Mechanics Research

  2026-08-28

  (-)-Blebbistatin is a reversible, cell-permeable non-muscle myosin II inhibitor for separating actomyosin-dependent mechanics from electrical signaling, migration, and adhesion phenotypes. This workflow-focused guide covers cardiac temperature assays, cytoskeletal dynamics research, dosing logic, controls, and troubleshooting.

• GANT61 Workflows for GLI Inhibition

  2026-08-28

  GANT61 provides a practical way to test GLI1/2-dependent transcription, tumor-cell fitness, and immune-evasion phenotypes in coordinated workflows. This guide connects dose-response experiments with WNT-, prostaglandin-, and checkpoint-resistance assays while emphasizing solvent control, target engagement, and interpretation.

• H2S Deficiency and ER Stress in Diabetic Cardiomyopathy

  2026-08-27

  The reference study identifies reduced endogenous hydrogen sulfide production as a mechanistic contributor to lipotoxic myocardial injury in diabetic cardiomyopathy. Using patient samples, diabetic rats, and palmitate-treated cardiomyocytes, it links H2S deficiency to endoplasmic reticulum stress and shows that H2S donation or ER-stress inhibition can reduce cardiac injury.

• N-MYC–eIF4G1 Survival Axis in inv(16) AML

  2026-08-27

  Peramangalam et al. identify N-MYC as a previously underappreciated survival regulator in inv(16) acute myeloid leukemia and connect it mechanistically to the translation-initiation factor eIF4G1. The study combines transcriptomic, enhancer, cellular, primary-sample, and xenograft evidence to define a CBFβ-SMMHC-associated survival pathway and suggest experiments for testing its therapeutic vulnerability.

• Annexin V-FITC/7-AAD Apoptosis Kit Guide

  2026-08-26

  The Annexin V-FITC/7-AAD Apoptosis Kit provides a rapid two-color method for separating viable, early apoptotic, late apoptotic, and membrane-compromised cells in flow cytometry or fluorescence microscopy workflows. It is suitable for cell viability and cytotoxicity assays, but it should not be used alone to identify apoptotic pathways or distinguish every form of regulated cell death.

• Allosteric PDK4 Inhibitors: Findings and Methods

  2026-08-26

  The 2019 Journal of Medicinal Chemistry study identified anthraquinone-derived allosteric pyruvate dehydrogenase kinase 4 inhibitors, with compound 8c showing nanomolar biochemical potency, favorable stability, and activity in metabolic, allergic, and cancer-related models. Its integrated biochemical, pharmacokinetic, docking, cellular, and animal experiments provide a useful framework for studying PDH activation and PDK4-directed metabolic intervention while highlighting the limits of translating preclinical findings into therapy.

• Lnc21q22.11 and MEK/ERK Signaling in Gastric Cancer

  2026-08-25

  A 2025 study identifies the 1202-nucleotide lncRNA Lnc21q22.11 as a gastric cancer suppressor regulated by histone methylation. Functional and xenograft experiments connect this transcript to MYH9 and MEK/ERK signaling, providing a mechanistic framework for studying lncRNA-based biomarkers and therapeutic combinations.

8016 records 1/535 page Next 12345 下5页 Last page